Archive
Past newsletters of MDDR.
Loading the archive
Past newsletters of MDDR.
Past newsletters of MDDR.
Tuesday, 9 June 2026
The federal government has issued new guidance clarifying the requirements for compounding medicines, as announced by the TGA. This guidance
Monday, 8 June 2026
Fourteen general practitioners received prestigious honours in this year’s King’s Birthday awards, recognising their contributions to primar
Sunday, 7 June 2026
CereVasc has raised $85 million in a Series C funding round led by Piper Sandler Merchant Banking, with participation from Johnson & Johnson
Saturday, 6 June 2026
AstraZeneca announced the discontinuation of the goserelin 3.6mg implant (Zoladex) in Australia, effective November 2026, citing a 'commerci
Friday, 5 June 2026
The Department of Health, Disability and Ageing (DoHDA) plans to improve visibility for doctors regarding claims made under their provider n
Thursday, 4 June 2026
The European Medicines Agency (EMA) is collaborating with the African Medicines Agency (AMA) and national regulatory authorities to address
Wednesday, 3 June 2026
The FDA has issued an early alert regarding the Abiomed 14Fr Low Profile Introducer Kit, indicating that prolonged use may lead to thrombus
Thursday, 28 May 2026
From 1 July 2026, Australian medical practices must obtain assignment of benefit consent from patients in an auditable electronic form to bu
Wednesday, 27 May 2026
Three Red Cross volunteers died in the Democratic Republic of the Congo (DRC) amid a rapidly spreading Ebola outbreak, with over 1000 cases
Tuesday, 26 May 2026
The Australian government has launched its first national awareness campaign focused on menopause and perimenopause, following recommendatio